Component

Human CXCR1/CXCR2 chemokine receptors

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Bromelain removed CXCR1/CXCR2 from human neutrophils and reduced IL-8-directed migration by about 40%.

    Bromelain → Human CXCR1/CXCR2 chemokine receptors source_derived_draftungraded
    Experimental context and source evidence
    dose
    In-vitro bromelain treatment; in-vivo preparation specified in the primary study
    duration
    Acute
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Isolated human neutrophils; three murine inflammation models
    limitations
    The effect was stimulus-selective and does not imply global suppression of neutrophil migration or human clinical efficacy.
    nutrient_topic
    Bromelain chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Bromelain
    organism
    Isolated human neutrophils; three murine inflammation models
    plain_language
    Bromelain removed CXCR1/CXCR2 from human neutrophils and reduced IL-8-directed migration by about 40%.
    primary_references
    Bromelain treatment decreases neutrophil migration to sites of inflammation. (2008). https://pubmed.ncbi.nlm.nih.gov/18482869/ DOI: 10.1016/j.clim.2008.02.015
    route
    In vitro and in vivo
    tissue
    Chemokine-receptor surface expression and chemotaxis

    Bromelain: mechanism of action and interactions (2026-09-20) · lines 33–42

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Isolated human neutrophils; three murine inflammation models · source_derived_draft · unverified_draft

    ## bromelain-neutrophil-cxcr Bromelain removed CXCR1/CXCR2 from human neutrophils and reduced IL-8-directed migration by about 40%. Model/species: Isolated human neutrophils; three murine inflammation models Tissue/system: Chemokine-receptor surface expression and chemotaxis Exposure: In-vitro bromelain treatment; in-vivo preparation specified in the primary study Route: In vitro and in vivo Duration: Acute Limits: The effect was stimulus-selective and does not imply global suppression of neutrophil migration or human clinical efficacy. Primary reference: Bromelain treatment decreases neutrophil migration to sites of inflammation. (2008). https://pubmed.ncbi.nlm.nih.gov/18482869/ DOI: 10.1016/j.clim.2008.02.015 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards